ARCHIVES

First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

CCOPs Extended One Year While Waiting Evaluation

May 17, 1985

NCI Offers Model Informed Consent Documents

November 6, 1998

Elderly Patients Fail To Receive New Cancer Therapy For CML

August 27, 2010

In Brief: Hatch Restores NCI Budget Bypass Authority In His Bill Renewing National Cancer Act

April 23, 1982

In Brief: Clark, Hutchinson Gain New Honors; Nominations Open For Bristol-Myers Award; NIH Appointments

July 1, 1983

Research Funding In Crisis; Scientists Fear Cancer Program’s Dismantling, AACR Says

January 20, 1995